Skip to content

Pilot evaluation of integrated CBT for depression

The pilot evaluation of an online platform for delivering integrated high-intensity Cognitive Behavioural Therapy for depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN14850613
Enrollment
43
Registered
2018-02-19
Start date
2018-03-01
Completion date
Unknown
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Primary care, Primary sub-specialty: Mental Health

Interventions

The study involves three strands of work running in parallel: 1. A longitudinal evaluation study with 12-16 primary care patients with depression, who will receive up to nine one-hour

Sponsors

University of Bristol
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Longitudinal study: 1. Aged 18 years or older 2. Score =14 on Beck Depression Inventory (BDI-II; Beck et al., 1996) 3. Meet ICD-10 criteria for depression (CIS-R; Lewis et al., 1992; Lewis, 1994) Therapists and Clinical Supervisors Working as therapists and clinical supervisors to deliver or supervise the INTERACT integrated therapy for this (Phase 2) study. Usability testing sessions 1. Aged 18 years or older 2. Have a history of depression 3. Have previously received high-intensity CBT for depression (online and/or face-to-face)

Exclusion criteria

Exclusion criteria: Longitudinal study with primary care patients: 1. Major alcohol or substance use problems (in the past year) 2. Have bipolar disorder, psychosis or dementia 3. Cannot complete questionnaires unaided 4. Are currently receiving CBT or other psychotherapy or secondary care for depression 5. Have received individual, high-intensity CBT in past 4 years 6. Taking part in another research study 7. Need an interpreter Usability testing sessions with service-users: 1. Unable to complete questionnaires 2. Have not received CBT for depression 3. Are currently receiving treatment from a psychiatrist for depression 4. Have a history of bipolar disorder, schizophrenia or personality disorder 5. Have a history of substance misuse/alcohol addiction (in the past year) 6. Are currently not well enough to attend a session 7. Have taken part in Phase 1 of the INTERACT study Therapists and clinical supervisors No exclusion criteria

Design outcomes

Primary

MeasureTime frame
The purpose of this study is to gather initial qualitative feedback on the integrated CBT platform. Clinical outcomes are not evaluated as part of this study. Qualitative feedback on the integrated CBT platform will be assessed as detailed below. 1. Patients in the longitudinal study will be interviewed by a researcher after their second or third therapy session, and again once they have completed therapy. Those who withdraw from therapy or are discharged for non-attendance will also be interviewed. The purpose of the qualitative interviews is to gather initial views on the platform, its content, and the experience with this integrated approach to delivering CBT. The System Usability Scale (SUS) will also be used to guide discussion of the platform. 2. Therapists and clinical supervisors will provide ongoing feedback regarding their experience of the platform. Data collection methods will include design discussion sessions, individual interviews and focus groups, and use of the System Usability Scale (SUS). 3. The usability testing sessions will be task-oriented and analysed qualitatively and results summarised by the task they relate to. Types of issues will be counted to identify the most common and most serious ones. The SUS scores will be analysed and interpreted.

Secondary

MeasureTime frame
There are no secondary outcome measures.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026